Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Humana ( (HUM) ) has shared an announcement.
On December 16, 2025, Humana announced the retirement of George Renaudin, Insurance Segment President, by Q3 2026 after a 29-year career. Aaron Martin will join as President of Medicare Advantage in January 2026 and succeed Renaudin as Insurance Segment President. John Barger will become President of Medicare Advantage. These leadership changes aim to strengthen Humana’s operations and continue its focus on value-based care and shareholder value creation.
The most recent analyst rating on (HUM) stock is a Hold with a $282.00 price target. To see the full list of analyst forecasts on Humana stock, see the HUM Stock Forecast page.
Spark’s Take on HUM Stock
According to Spark, TipRanks’ AI Analyst, HUM is a Neutral.
Humana’s overall stock score reflects solid financial performance and positive earnings call sentiment, despite technical and valuation challenges. The company’s strategic initiatives and operational efficiency improvements are promising, but profitability and cash flow management need attention.
To see Spark’s full report on HUM stock, click here.
More about Humana
Humana is a leading U.S. healthcare company offering insurance services and CenterWell health care services. It aims to improve the quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities.
Average Trading Volume: 1,801,522
Technical Sentiment Signal: Sell
Current Market Cap: $32.29B
For an in-depth examination of HUM stock, go to TipRanks’ Overview page.